Non-Acinetobacter baumannii spp. are emerging among clinical Acinetobacter isolates causing nosocomial infections, and some (such as genomospecies 13TU) appear to be multidrug resistant. The prevalence of non-Acinetobacter baumannii spp. in the hospital setting is likely understated due to poor identification techniques. We report the first identification of an AdeABC-type efflux pump in an Acinetobacter genomospecies 13TU clinical isolate, its contribution to multidrug resistance, and the coexistence of three Ade-type efflux pumps in this strain.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3067064 | PMC |
| http://dx.doi.org/10.1128/AAC.01142-10 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The Acinetobacter baumannii group: a systemic review.
World J Emerg Med
September 2014
Department of Emergency Medicine, First Affiliated Hospital, Nanjing Medical University, Nanjing 210029, China.
Background: The Acinetobacter baumannii group, including Acinetobacter baumannii, Acinetobacter genomospecies 3 and 13TU, is phenotypically indistinguishable and uniformly identified as Acinetobacter baumannii by laboratories of clinical microbiology. This review aimed to demonstrate the differences among them.
Methods: Literatures associated with the Acinetobacter baumannii group were identified and selected from PubMed databases and relevant journals.
Characteristics of carbapenem-resistant Acinetobacter spp. other than Acinetobacter baumannii in South Korea.
Int J Antimicrob Agents
January 2012
Department of Molecular Cell Biology, Samsung Biomedical Research Institute, Sungkyunkwan University School of Medicine, Suwon, South Korea.
Although many studies have been performed on carbapenem-resistant Acinetobacter baumannii, only a few studies have addressed carbapenem resistance in Acinetobacter spp. other than A. baumannii (non-baumannii Acinetobacter).
View Article and Find Full Text PDFClinical impact and molecular basis of antimicrobial resistance in non-baumannii Acinetobacter.
Future Microbiol
May 2011
Department of Microbiology, Hospital Clinic, School of Medicine, University of Barcelona, CRESIB, IDIBAPS, Spain.
Species of Acinetobacter other than Acinetobacter baumannii are involved in nosocomial infections. Acinetobacter lwoffii, Acinetobacter genomospecies 3 and Acinetobacter genomospecies 13TU are found in community- and nosocomial-acquired infections as well as in neonatal intensive care units. The non-baumannii Acinetobacter are normally highly susceptible to ciprofloxacin, ampicillin/sulbactam, gentamicin and tigecycline.
View Article and Find Full Text PDFFirst identification and characterization of an AdeABC-like efflux pump in Acinetobacter genomospecies 13TU.
Antimicrob Agents Chemother
March 2011
Department of Microbiology, Hospital Clínic, School of Medicine, University of Barcelona, CRESIB, Barcelona, Spain.
Non-Acinetobacter baumannii spp. are emerging among clinical Acinetobacter isolates causing nosocomial infections, and some (such as genomospecies 13TU) appear to be multidrug resistant. The prevalence of non-Acinetobacter baumannii spp.
View Article and Find Full Text PDFIdentification of Acinetobacter species and genotyping of Acinetobacter baumannii by multilocus PCR and mass spectrometry.
J Clin Microbiol
August 2006
Ibis Biosciences, Isis Pharmaceuticals, Inc., 1891 Rutherford Road, Carlsbad, CA 92008, USA.
Members of the genus Acinetobacter are ubiquitous in soil and water and are an important cause of nosocomial infections. A rapid method is needed to genotype Acinetobacter isolates to determine epidemiology and clonality during infectious outbreaks. Multilocus PCR followed by electrospray ionization mass spectrometry (PCR/ESI-MS) is a method that uses the amplicon base compositions to genotype bacterial species.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!